Department of Pharmaceutical & Health Sciences, Faculty of Pharmacy, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Alcorcón, 28925 Madrid, Spain.
Grupo USP-CEU de Excelencia "Nutrición para la vida (Nutrition for Life)", Ref: E02/0720, Alcorcón, 28925 Madrid, Spain.
Nutrients. 2022 Apr 15;14(8):1659. doi: 10.3390/nu14081659.
The extracellular mass/body cell mass ratio (ECM/BCM ratio) is a novel indicator of nutritional and hydration status in hemodialysis (HD) patients. This study aimed to explore the ECM/BCM ratio as a predictor of mortality risk with nutritional-inflammatory markers in HD patients. A prospective observational study was conducted in 90 HD patients (male: 52.2%; DM: 25.60%). Clinical and biochemical parameters [serum albumin, serum C-reactive protein (s-CRP), interleukine-6 (IL-6)] were analysed and bioelectrical impedance analysis (BIA) was performed. Protein-energy wasting syndrome (PEW) was diagnosed using malnutrition-inflammation score (MIS). Based on BIA-derived measurements, the ECM/BCM ratio with a cut-off point of 1.20 was used as a PEW-fluid overload indicator. Comorbidity by Charlson index and hospital admissions were measured. Out of 90 HD patients followed up for 36 months, 20 patients (22.22%) died. PEW was observed in 24 survivors (34.28%) and all non-survivors. The ECM/BCM ratio was directly correlated with MIS, s-CRP, Charlson index and hospital admissions but was negatively correlated with phase angle and s-albumin (all, p < 0.001). Values of the ECM/BCM ratio ≥ 1.20 were associated with higher probability of all-cause mortality (p = 0.002). The ECM/BCM ratio ≥ 1.20, IL-6 ≥ 3.1 pg/mL, s-CRP and s-albumin ≥ 3.8 g/dL and Charlson index were significantly associated with all-cause mortality risk in multivariate adjusted analysis. This study demonstrates that the ECM/BCM ratio ≥ 1.20 as a nutritional marker and/or fluid overload indicator had a significant prognostic value of death risk in HD patients.
细胞外基质/身体细胞质量比(ECM/BCM 比)是血液透析(HD)患者营养和水合状态的新指标。本研究旨在探讨 ECM/BCM 比作为 HD 患者营养-炎症标志物预测死亡风险的指标。对 90 名 HD 患者(男性:52.2%;DM:25.60%)进行前瞻性观察研究。分析临床和生化参数[血清白蛋白、血清 C 反应蛋白(s-CRP)、白细胞介素-6(IL-6)]并进行生物电阻抗分析(BIA)。使用营养不良-炎症评分(MIS)诊断蛋白质-能量消耗综合征(PEW)。根据 BIA 测量结果,将 ECM/BCM 比与 1.20 的切点用作 PEW-液体超负荷的指标。通过 Charlson 指数和住院治疗来衡量合并症。在随访 36 个月的 90 名 HD 患者中,有 20 名患者(22.22%)死亡。24 名幸存者(34.28%)和所有非幸存者均存在 PEW。ECM/BCM 比与 MIS、s-CRP、Charlson 指数和住院治疗直接相关,但与相位角和 s-白蛋白呈负相关(均,p < 0.001)。ECM/BCM 比≥1.20 的值与全因死亡率的可能性更高相关(p = 0.002)。在多变量调整分析中,ECM/BCM 比≥1.20、IL-6≥3.1pg/mL、s-CRP 和 s-白蛋白≥3.8g/dL 以及 Charlson 指数与全因死亡率风险显著相关。本研究表明,ECM/BCM 比≥1.20 作为营养标志物和/或液体超负荷指标,对 HD 患者死亡风险具有显著的预后价值。